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w kt6rej zawarto pytania 0 ich oczekiwania
w stosunku do lekarza, piel~gniarki, psy-
chologa i technika radioterapii. Zadaniem
badanych byto ustalenie hierarchii wat.-
nosci nast~pujqcych okresler'1: usmiech,
rozmowa, pocieszenie, doswiadczenie
w pracy, zdecydowanie, cierpliwosc, infor-
macja na temat choroby i przebiegu te-
rapii, fachowosc.
Wyniki. Pacjenci oczekujq od: - lekarza -
informacji, usmiechu i doswiadczenia za-
wodowego - piel~gniarki - usmiechu i roz-
mowy - psychologa - rozmowy i pociesze-
nia - technika radioterapii - doswiadczenia
w pracy i rozmowy.
Wniosk. 1. Wszystkie osoby sprawujqce
profesjonalnq opiekE? nad pacjentami
z chorobq nowotworoWq wzajemnie
uzupetniajq si~ i zaspokajajq ich potrzeby
w trakcie prowadzonej terapii.
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Bladder cancer is the second most
common malignancy of the genitourinary
tract. The efficacy of RT in more advanced
disease or loco-regional recurrences is
unsatisfactory. Surgery remains a main-
stay of radical treatment, whereas radical
radiotherapy alone or radiotherapy pre-
ceded by induction chemotherapy are
optional organ-sparing methods. In our
institution indications for external beam
irradiation include positive surgical mar-
gins, T3 or N2. Here we present the
analysis of treatment tolerance and patient
survival in a consecutive series of patients
who underwent postoperative radiotherapy
for bladder cancer between 1992 and
2002.
Patients and methods: Hospital charts
of 51 patients (3 w')men and 48 men,
median age 64 years), were retrospect-
tively reviewed. T2, T3a, T3b and T4a
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stages were diagnosed in 14, 18, 7 and 11
cases respectively. Eleven patients
underwent radical cystectomy (8 Bricker-
type and 3 other-type radical cystecto-
mies), and in the remaining 40 patients
transuretheral resection only was perfor-
med. In all cases surgical treatment was
followed by conventionally fractionated
megavoltage radiotherapy (two antero-
posterior opposed fields) delivered to the
whole pelvis to the total dose of 45-48 Gy,
followed in 44 patients by a boost to the
bladder to the total dose of 54-70 Gy
(median 60 Gy; three- or four-field
technique).
Results: At a follow-up time of 4-119
months (median 22 months), 14 patients
(27%) have been alive for a median of 47
months. Median actuarial survival for the
whole group was 33.6 months. One patient
was lost to follow-up. Acute toxic side-
effects of treatment included grade 3 or 4
diarrhoea in 12 patients, dysuria in 14
patients, and both aforementioned side-
effects in 5. Grade 3 acute side-effects
occurred only in patients who received the
total dose of at least 50 Gy. Median total
dose in patients who experienced grade
3 bowel toxicity and bladder toxicity was
58.5 Gy and 60.3 Gy, respectively. At the
total dose range of 50-59 Gy, 2 out of 14
patients experienced grade 3 dysuria, and
5 of 12 had bowel problems. Other
(12 bladder, 7 bowel) toxicities were seen
at the total dose of at least 60 Gy. 23
patients (45%) did not report any serious
acute reactions.
Conclusion: Radiotherapy for bladder
cancer is associated with manageable
early toxicity, but its efficacy is still far from
satisfactory.
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IN VIVO MEASUREMENTS
OF ENTRANCE DOSES IN 60CO
TELETHERAPY USING
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AMG
The results of in vivo dosimetry in radio-
therapy using alanine detectors are pre-
sented. This dosimetric method is based
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